You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Details for New Drug Application (NDA): 202813

✉ Email this page to a colleague

NDA 202813 describes QNASL, which is a drug marketed by Teva Branded Pharm and is included in one NDA. It is available from one supplier. There is one patent protecting this drug. Additional details are available on the QNASL profile page.

The generic ingredient in QNASL is beclomethasone dipropionate. There are twenty drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the beclomethasone dipropionate profile page.

Summary for 202813

Tradename:	QNASL
Applicant:	Teva Branded Pharm
Ingredient:	beclomethasone dipropionate
Patents:	1

Pharmacology for NDA: 202813

Mechanism of Action	Corticosteroid Hormone Receptor Agonists

Suppliers and Packaging for NDA: 202813

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
QNASL	beclomethasone dipropionate	AEROSOL, METERED;NASAL	202813	NDA	Teva Respiratory, LLC	59310-406	59310-406-06	1 INHALER in 1 CARTON (59310-406-06) / 60 AEROSOL, METERED in 1 INHALER
QNASL	beclomethasone dipropionate	AEROSOL, METERED;NASAL	202813	NDA	Teva Respiratory, LLC	59310-406	59310-406-08	1 INHALER in 1 CARTON (59310-406-08) / 60 AEROSOL, METERED in 1 INHALER

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	AEROSOL, METERED;NASAL			Strength	0.08MG/ACTUATION
Approval Date:	Mar 23, 2012	TE:		RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	Oct 21, 2031	Product Flag?	Y	Substance Flag?		Delist Request?

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	AEROSOL, METERED;NASAL			Strength	0.04MG/ACTUATION
Approval Date:	Dec 17, 2014	TE:		RLD:	Yes
Patent:	⤷ Start Trial	Patent Expiration:	Oct 21, 2031	Product Flag?	Y	Substance Flag?		Delist Request?

Expired US Patents for NDA 202813

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Teva Branded Pharm	QNASL	beclomethasone dipropionate	AEROSOL, METERED;NASAL	202813-002	Dec 17, 2014	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QNASL	beclomethasone dipropionate	AEROSOL, METERED;NASAL	202813-001	Mar 23, 2012	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QNASL	beclomethasone dipropionate	AEROSOL, METERED;NASAL	202813-001	Mar 23, 2012	⤷ Start Trial	⤷ Start Trial
Teva Branded Pharm	QNASL	beclomethasone dipropionate	AEROSOL, METERED;NASAL	202813-001	Mar 23, 2012	⤷ Start Trial	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.